期刊文献+

流式细胞术微球阵列法检测急性白血病血清IL-6、IL-10和TNF水平 被引量:13

The levels of Il-6,IL-10,TNF detected by cytometric bead array during acute leukemia
下载PDF
导出
摘要 目的:探讨流式细胞术微球阵列法(CBA)在细胞因子检测中的应用及血清肿瘤坏死因子(TNF)、白细胞介素6(IL-6)和白细胞介素10(IL-10)在不同亚型急性白血病(AL)中的表达水平。方法:采用BD CBA F lex Set IL-6、IL-10、TNF试剂盒和流式细胞术检测29例急性白血病患者和20例正常人血清样本中3种细胞因子水平。结果:AL患者IL-6、IL-10和TNF水平显著高于正常对照组,急性淋巴细胞白血病(ALL)的IL-10和TNF水平较急性非淋巴细胞白血病(ANLL)有显著性提高(P<0.05)。在ANLL亚型中,M1型IL-6水平最高。结论:CBA法能快速、准确地定量检测细胞因子;AL血清中IL-6、IL-10和TNF水平升高,可能与疾病的发生发展存在相关性。 Aim: To explore the application of cytometric bead array (CBA) method in detection of cytokines and detect the levels of IL-6,IL-10 and interferon (IFN) in the serum from patients with different subtypes of acute leukemia(AL). Methods: The levels of three cytokines (IFN, IL-6, and IL-10) in the serum from 29 cases of patients with AL and 20 cases of normal persons were detected by using flow cytometry and BD CBA Flex Set kit. Results: The levels of IFN, IL-6, and IL-10 in AL group were significantly higher than those in controls. Compared with acute non-lymphoid leukemia (ANLL) group, the levels of IFN and IL-10 in acute lymphoid leukemia (ALL) group were significantly higher (P 〈0.05). The level of IL-6 in M1 was the highest among the ANLL subtypes. Conclusion: Detecting cytokines by CBA method is quick and accurate; IFN, IL-6, and IL-10 might take part in the process of AL according to their increased levels in AL.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2008年第4期375-377,共3页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 国家重点基础研究规划项目973计划项目(2004CB720100) 国家重点基础研究发展计划973项目(2006CB504201) 生物化学与分子生物学广东省重点学科项目
关键词 流式细胞术微球阵列法 急性白血病 细胞因子 cytometric bead array acute leukemia cytokine
  • 相关文献

参考文献9

  • 1CAMILLA C, DEFORT J P, DELAAGE M, et al. A new flow cytometry-based multi-assay system Application to cytokine immunoassays [ J ]. Cytometry Suppl, 1998, 8 : 132.
  • 2MOQATTASH S, LIJTrON J D. Leukemia ceils and the cytokine network[J]. Proc Soc Exp Biol Med, 1998, 219 (1) :8 -27.
  • 3VAN ETTZN R A. Aberrant cytokine signaling in leukemia[J]. Oncngene, 2007, 26(47):6738-6749.
  • 4MORGAN E, VARRO R, SEPULVEDA H, et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology[ J]. Clin Immunol, 2004, 110:252-266.
  • 5MOQATTASH S, LUTTON J D. Leukemia cells and the cytokine network: therapeutic prospects [ J ]. Exp Biol Med, 2004, 229(1) :121 -127.
  • 6叶丽萍,施兵,刘莉.急性白血病患者血清、脑脊液IL-6水平及临床意义[J].放射免疫学杂志,2006,19(1):7-9. 被引量:2
  • 7GIBBS J D, LIEBERMANN D A, HOFFMAN B, et al. Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia [ J ]. Oncogene, 2008, 27(1) :98 - 106.
  • 8VESELY D L, HOFFMAN B, LIEBERMANN D A, et al. Phosphatidylinositol 3-kinasa/Akt signaling mediates interleuldn-6 protection against p53-induced apoptosis in M1 myeloid leukemia leukemic cells [ J ]. Oncogene, 2007, 26(21) :3041 -3050.
  • 9DOUILLARD J Y, CUNNINGHAM D, ROTH A D, et al. Irinotecan combined with fluorouracil compared with fluorouracil aline as first-line treatment for metestatic colorectal cancer: a multicenter randomized trial [J]. Lancet, 2000, 355:1040 - 1047.

二级参考文献7

共引文献1

同被引文献105

引证文献13

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部